COMPARE · Reviewed July 29, 2026

CCJ vs HCC

Verdict: Side-by-side breakdown using the Bull Rankings model. CCJ scored 27.5, HCC scored 33.8 — HCC leads.
Compare another set
CCJ
Cameco Corp
Energy · Quality-Growth
27.5
$87.89 · $38.0B
Score gap
6.3
HCC leads
HCC
Warrior Met Coal, Inc.
Coking Coal · Quality-Growth
33.8
$80.36 · $4.2B
fundamentals as of
THE BULL RANKINGS SCORECARD28/ 100 · BULL SCOREPEER MEDIANQUALITY61GROWTH68VALUE0
THE BULL RANKINGS SCORECARD34/ 100 · BULL SCOREPEER MEDIANQUALITY44GROWTH50VALUE18
CCJ
stronger →← stronger
HCC
61
Qualityreturns · margins · balance sheet
44
68
Growthrevenue & earnings expansion
50
0
Valuevaluation vs sector peers
18
CCJ is stronger on 2 of 3 pillars.
CCJ
HCC
FCF
-$189mF
+7.5%B
Rev
+11.1%B
0.14A-
D/E
0.11A-
79.5xD+
P/E
10.63D
PEG
P/S
2.9xB
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
CCJ
No notable signals flagged.
HCC
Why this score
  • Cyclical growth
CCJCameco Corp
Energy · $87.89 · beta 1.09
Why now
Energy · market cap $38.0b. Down 35% from 52-week high of $135.24 — deep drawdown territory.
Moat
Net margin 18% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent.
Risk
Trailing P/E 79.5x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Down 35% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. P/S 14.6x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
HCCWarrior Met Coal, Inc.
Coking Coal · $80.36 · beta 0.67
Why now
Coking Coal · market cap $4.2b. Down 27% from 52-week high of $110.39 — deep drawdown territory. Revenue growing +11%, comfortably above the S&P median. 6 sell-side analysts rate this a Buy with a mean 1-yr target of $103.00 (implying +28% upside).
Moat
Turnaround / out-of-favor name — GAAP-unprofitable for now, so the durability case is forward-looking: it rests on a recovery (margin normalization, a cyclical upturn or restructuring) or an un-monetized asset (IP / network effects / first-mover position) rather than on current reported results.
Risk
Free cash flow is negative (-$189m) — capital raises or debt issuance likely required; dilution / leverage risk. Trailing P/E 31x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. ROE 6% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.